IMA-PB

Inverness Medical Innovations, Inc.

Global leader in rapid point-of-care diagnostics and health management services, including home pregnancy and fertility tests (Clearblue), infectious disease, cardiology, and drugs-of-abuse testing.

Series B Convertible Perpetual Preferred Stock — Acquired by Abbott (via Alere) in 2017

Recent Activity

Show $

2010Q3

1 sell

ValueAct CapitalEXIT

-48.3K shares

ValueAct CapitalEXIT

-48.3K shares

2010Q2

1 buy

ValueAct CapitalADD

+542 shares(+1.1%)

ValueAct CapitalADD

+542 shares(+1.1%)

2010Q1

1 buy

ValueAct CapitalADD

+527 shares(+1.1%)

ValueAct CapitalADD

+527 shares(+1.1%)

Loading more activity...